JP Morgan Private Wealth Advisors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio SZYM Stock Details SZYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-17,314	Closed	-$35K	–	1360
2016 Q1	$35K	Buy	17,314 +2,007	+13%	+$3.58K	﹤0.01%	1207
2015 Q4	$38K	Hold	15,307	–	–	﹤0.01%	1099
2015 Q3	$40K	Buy	+15,307	New	+$39.9K	﹤0.01%	1035
2015 Q1	–	Sell	-15,307	Closed	-$39K	–	1192
2014 Q4	$39K	Sell	15,307 -450	-3%	-$1.97K	﹤0.01%	1078
2014 Q3	$117K	Buy	+15,757	New	+$147K	﹤0.01%	1032

JP Morgan Private Wealth Advisors's SZYM Position: Q2 2016 in Review

JP Morgan Private Wealth Advisors sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 17,314 shares — an estimated $35K sold.

JP Morgan Private Wealth Advisors first reported a position in SZYM in Q3 2014 and held it in 5 quarters. The position peaked at $117K in Q3 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

JP Morgan Private Wealth Advisors reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 17,314 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $35K.
JP Morgan Private Wealth Advisors first reported a position in SOLAZYME INC COM STK (DE) in Q3 2014 and held it in 5 quarters.
JP Morgan Private Wealth Advisors's SOLAZYME INC COM STK (DE) position peaked at $117K in Q3 2014.
0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.